Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Biopharma Inc (NASDAQ:TBPH)

28.62
Delayed Data
As of 4:00pm ET
 +1.20 / +4.38%
Today’s Change
12.87
Today|||52-Week Range
38.92
+74.62%
Year-to-Date
No recent news for Theravance Biopharma Inc.

Today’s Trading

Previous close27.42
Today’s open27.45
Day’s range26.80 - 28.84
Volume235,463
Average volume (3 months)407,702
Market cap$1.4B
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+28.42%
Earnings growth (this year)+28.09%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)+260.42%
P/E ratioNM
Price/Sales13.29
Price/Book4.28

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...+0.50+1.27%
CLVSClovis Oncology Inc+0.47+1.32%
ARRYArray Biopharma Inc+0.29+3.66%
AXONAxovant Sciences Ltd+0.10+0.75%
Data as of 4:01pm ET, 12/02/2016

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$1.04
Annual revenue (last year)$42.1M
Annual profit (last year)-$182.2M
Net profit margin-432.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Senior VP &
Global Head-Acute Care Business
Frank C. Pasqualone
Corporate headquarters
George Town, George Town

Forecasts


Search for Jobs